Found 9 matching trials
BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients PHASE4 The prior BEEP study involved patients being switched between brand and gen...
Show More Location
University of Maryland
Learn More & Join Trial
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure PHASE3 Schizophrenia, bipolar and major depressive disorders collectively affect o...
Show More Location
Sheba Medical Center
Learn More & Join Trial
Lamotrigine Bioequivalence PHASE4 In this study, brand name lamotrigine (LAMICTAL) and generic lamotrigine wi...
Show More Location
University of Maryland
Learn More & Join Trial
Characterization of Epilepsy Patients BEEP 2b PHASE1 Some epilepsy patients are described as GB when they have worsened seizures...
Show More Location
University of Maryland, Baltimore
Learn More & Join Trial
A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects PHASE1 The objective of this study is to determine bioequivalence between two diff...
Show More Location
Vince and Associates Clinical Research, Inc
Learn More & Join Trial
Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants N/A There is a significant lack of information on drug secretion into milk and ...
Show More Learn More & Join Trial
A Trial of Generic Substitution of Antiepileptic Drugs PHASE4 Background. Anecdotal reports and uncontrolled studies have described an as...
Show More Location
Clinica Neurologica Amaducci, Policlinico di Bari
Learn More & Join Trial
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) PHASE4 The United States Food and Drug Administration (FDA) has specific rules whi...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design PHASE4 The United States Food and Drug Administration (FDA) has specific rules gen...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial